US 8466188
Use of spiro-oxindole compounds as therapeutic agents
granted A61KA61K31/407A61K31/437
Quick answer
US patent 8466188 (Use of spiro-oxindole compounds as therapeutic agents) held by Xenon Pharmaceuticals Inc. expires Mon Jun 13 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Xenon Pharmaceuticals Inc.
- Grant date
- Tue Jun 18 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 13 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 1
- CPC classes
- A61K, A61K31/407, A61K31/437, A61P, A61P13/08